 | • レポートコード：360iR22NB218 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、228ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査レポートによると、世界のウェアラブル医療機器市場規模が、2021年に297.2億ドル、2022年に337.8億ドルと推定され、2027年までにCAGR13.91%で成長し、649.4億ドルに達する見通しとなっています。当書では、ウェアラブル医療機器の世界市場について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（衣類、耳用装具、ヘッドバンド、靴センサー、その他）分析、機器タイプ別（心電計、神経モニタリング機器、睡眠モニタリング機器、バイタルサインモニタリング機器）分析、用途別（心臓健康管理、糖尿病ケア、一般健康管理＆フィットネス、在宅医療、その他）分析、産業別（家電、企業＆機関、医療、メディア＆エンターテインメント）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目を掲載しています。なお、当書には、Abbott Laboratories、Apple Inc.、BioTelemetry Inc.、Contec Medical Systems Co. Ltd.、Dexcom Inc.、Fitbit Inc.、Garmin Ltd.、GE Healthcare、iRhythm Technologies Inc.、Koninklijke Philips N.V.、Masimo Corporation、MediBioSense Ltd.、Medtronic PLCなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のウェアラブル医療機器市場規模：製品別 - 衣類の市場規模 - 耳用装具の市場規模 - ヘッドバンドの市場規模 - 靴センサーの市場規模 - その他ウェアラブル医療機器の市場規模 ・世界のウェアラブル医療機器市場規模：機器タイプ別 - 心電計の市場規模 - 神経モニタリング機器の市場規模 - 睡眠モニタリング機器の市場規模 - バイタルサインモニタリング機器の市場規模 ・世界のウェアラブル医療機器市場規模：用途別 - 心臓健康管理における市場規模 - 糖尿病ケアにおける市場規模 - 一般健康管理＆フィットネスにおける市場規模 - 在宅医療における市場規模 - その他用途における市場規模 ・世界のウェアラブル医療機器市場規模：産業別 - 家電における市場規模 - 企業＆機関における市場規模 - 医療における市場規模 - メディア＆エンターテインメントにおける市場規模 ・世界のウェアラブル医療機器市場規模：地域別 - 南北アメリカのウェアラブル医療機器市場規模 アメリカのウェアラブル医療機器市場規模 カナダのウェアラブル医療機器市場規模 ブラジルのウェアラブル医療機器市場規模 ... - アジア太平洋のウェアラブル医療機器市場規模 日本のウェアラブル医療機器市場規模 中国のウェアラブル医療機器市場規模 インドのウェアラブル医療機器市場規模 韓国のウェアラブル医療機器市場規模 台湾のウェアラブル医療機器市場規模 ... - ヨーロッパ/中東/アフリカのウェアラブル医療機器市場規模 イギリスのウェアラブル医療機器市場規模 ドイツのウェアラブル医療機器市場規模 フランスのウェアラブル医療機器市場規模 ロシアのウェアラブル医療機器市場規模 ... - その他地域のウェアラブル医療機器市場規模 ・競争状況 ・企業情報 |
The Global Wearable Healthcare Devices Market size was estimated at USD 29.72 billion in 2021 and expected to reach USD 33.78 billion in 2022, and is projected to grow at a CAGR 13.91% to reach USD 64.94 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Wearable Healthcare Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Clothing, Ear Wear, Headband, Shoe Sensors, Smartwatch, and Trackers.
Based on Device Type, the market was studied across Diagnostic Devices. The Diagnostic Devices is further studied across Electrocardiographs Fetal and Obstetric Devices, Neuromonitoring Devices, Sleep Monitoring Devices, and Vital Sign Monitoring Devices.
Based on Therapeutic Devices, the market was studied across Insulin Delivery Devices, Pain Management Devices, Rehabilitation Devices, and Respiratory Therapy Devices.
Based on Grade, the market was studied across Clinical and Consumer.
Based on Channel, the market was studied across E-commerce, Pharmacies, and Supermarkets/Hypermarkets.
Based on Application, the market was studied across Cardiac Health, Diabetes care, General Health and Fitness, Home Healthcare, Obesity Control, and Remote Patient Monitoring.
Based on End-Use Industry, the market was studied across Consumer Electronics, Enterprise & Industrial, Healthcare, and Media & Entertainment.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Wearable Healthcare Devices market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Wearable Healthcare Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Wearable Healthcare Devices Market, including Abbott Laboratories, Apple Inc., BioTelemetry Inc., Contec Medical Systems Co. Ltd., Dexcom Inc., Fitbit Inc., Garmin Ltd., GE Healthcare, iRhythm Technologies Inc., Koninklijke Philips N.V., Masimo Corporation, MediBioSense Ltd., Medtronic PLC, OMRON Corporation, and Preventice Solutions Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Wearable Healthcare Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Wearable Healthcare Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Wearable Healthcare Devices Market?
4. What is the competitive strategic window for opportunities in the Global Wearable Healthcare Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Wearable Healthcare Devices Market?
6. What is the market share of the leading vendors in the Global Wearable Healthcare Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Wearable Healthcare Devices Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing preference for wireless connectivity among healthcare providers
5.1.1.2. Rapidly increasing home healthcare and remote patient monitoring devices
5.1.1.3. Rising focus on fitness and a healthy lifestyle orientation globally
5.1.2. Restraints
5.1.2.1. Concerns regarding high cost of wearable healthcare devices
5.1.3. Opportunities
5.1.3.1. Favorable government initiatives for use of wearable medical instruments
5.1.3.2. Rising technological innovations and advancements in wearable healthcare devices
5.1.4. Challenges
5.1.4.1. Lack of awareness about the availability of wearable devices in developing and underdeveloped countries
5.2. Cumulative Impact of COVID-19
6. Wearable Healthcare Devices Market, by Product
6.1. Introduction
6.2. Clothing
6.3. Ear Wear
6.4. Headband
6.5. Shoe Sensors
6.6. Smartwatch
6.7. Trackers
7. Wearable Healthcare Devices Market, by Device Type
7.1. Introduction
7.2. Diagnostic Devices
7.3.1. Electrocardiographs Fetal and Obstetric Devices
7.3.2. Neuromonitoring Devices
7.3.3. Sleep Monitoring Devices
7.3.4. Vital Sign Monitoring Devices
8. Wearable Healthcare Devices Market, by Therapeutic Devices
8.1. Introduction
8.2. Insulin Delivery Devices
8.3. Pain Management Devices
8.4. Rehabilitation Devices
8.5. Respiratory Therapy Devices
9. Wearable Healthcare Devices Market, by Grade
9.1. Introduction
9.2. Clinical
9.3. Consumer
10. Wearable Healthcare Devices Market, by Channel
10.1. Introduction
10.2. E-commerce
10.3. Pharmacies
10.4. Supermarkets/Hypermarkets
11. Wearable Healthcare Devices Market, by Application
11.1. Introduction
11.2. Cardiac Health
11.3. Diabetes care
11.4. General Health and Fitness
11.5. Home Healthcare
11.6. Obesity Control
11.7. Remote Patient Monitoring
12. Wearable Healthcare Devices Market, by End-Use Industry
12.1. Introduction
12.2. Consumer Electronics
12.3. Enterprise & Industrial
12.4. Healthcare
12.5. Media & Entertainment
13. Americas Wearable Healthcare Devices Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Wearable Healthcare Devices Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Wearable Healthcare Devices Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Abbott Laboratories
17.1.1. Business Overview
17.1.2. Key Executives
17.1.3. Product & Services
17.2. Apple Inc.
17.2.1. Business Overview
17.2.2. Key Executives
17.2.3. Product & Services
17.3. BioTelemetry Inc.
17.3.1. Business Overview
17.3.2. Key Executives
17.3.3. Product & Services
17.4. Contec Medical Systems Co. Ltd.
17.4.1. Business Overview
17.4.2. Key Executives
17.4.3. Product & Services
17.5. Dexcom Inc.
17.5.1. Business Overview
17.5.2. Key Executives
17.5.3. Product & Services
17.6. Fitbit Inc.
17.6.1. Business Overview
17.6.2. Key Executives
17.6.3. Product & Services
17.7. Garmin Ltd.
17.7.1. Business Overview
17.7.2. Key Executives
17.7.3. Product & Services
17.8. GE Healthcare
17.8.1. Business Overview
17.8.2. Key Executives
17.8.3. Product & Services
17.9. iRhythm Technologies Inc.
17.9.1. Business Overview
17.9.2. Key Executives
17.9.3. Product & Services
17.10. Koninklijke Philips N.V.
17.10.1. Business Overview
17.10.2. Key Executives
17.10.3. Product & Services
17.11. Masimo Corporation
17.11.1. Business Overview
17.11.2. Key Executives
17.11.3. Product & Services
17.12. MediBioSense Ltd.
17.12.1. Business Overview
17.12.2. Key Executives
17.12.3. Product & Services
17.13. Medtronic PLC
17.13.1. Business Overview
17.13.2. Key Executives
17.13.3. Product & Services
17.14. OMRON Corporation
17.14.1. Business Overview
17.14.2. Key Executives
17.14.3. Product & Services
17.15. Preventice Solutions Inc.
17.15.1. Business Overview
17.15.2. Key Executives
17.15.3. Product & Services
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing